<乌鸦传媒>Low-Salt Diet Helpful for HF Symptoms, but Not Necessarily for Clinical Events Sodium restriction still holds its ground in SODIUM-HF trial Apr 02, 2022
<乌鸦传媒>Tranexamic Acid Cuts Surgical Bleeding in Yet Another Setting But POISE-3 trial leaves open the question of cardiovascular safety Apr 02, 2022
<乌鸦传媒>From 'Pre-HF' to 'HFimpEF': Guidelines Redefine Heart Failure Stages, Classes Update also adds SGLT2 inhibitor as a pillar of therapy Apr 01, 2022
<乌鸦传媒>In-Person ACC Meeting Returns, Serving Diet Intervention Studies and More Will salt restriction finally get a boost at this weekend's meeting? Mar 31, 2022
<乌鸦传媒>Xarelto Flops for COVID-19 Clot Prevention Outside ICU ACTION trial adds nuance to the story from large platform trials May 19, 2021
<乌鸦传媒>Burnout in Cardiology; Restrictive Transfusion Foiled; and Other News From ACC Highlights from the scientific program of the American College of Cardiology meeting May 18, 2021
<乌鸦传媒>Setbacks for Invasive Strategy, Moderate Cooling in Cardiac Arrest Prague OHCA study, CAPITAL CHILL give some answers for out-of-hospital cardiac arrest treatment May 18, 2021
<乌鸦传媒>Falling Through the Cracks on Rapid Troponin Testing Protocols Studies point to potential risks and pitfalls with change to more sensitive, rapid testing May 18, 2021
<乌鸦传媒>Novel Heart Failure Agent Works Best in Sickest Patients Omecamtiv mecarbil provides benefit to those with low LVEF May 18, 2021
<乌鸦传媒>Plavix Beats Aspirin, Brilinta After Stenting HOST-EXAM and TALOS-AMI studies from South Korea focus on aspects of DAPT May 18, 2021
<乌鸦传媒>Finerenone May Delay AFib Onset in Patients With CKD and Diabetes Risk of kidney or CV events reduced regardless of atrial fibrillation or atrial flutter history May 18, 2021
<乌鸦传媒>Entresto Risky for Advanced Heart Failure? LIFE trial "not only disappointed but surprised" with its findings May 17, 2021
<乌鸦传媒>Stubborn Gaps in Heart Failure Persist Despite Clinician Education, Feedback Guideline-directed medical therapy underuse still a problem in CONNECT-HF trial May 17, 2021
<乌鸦传媒>Personalized Rehab Helpful in Heart Failure Patients Trial showed improvements in physical functioning and quality of life compared with usual care May 17, 2021
<乌鸦传媒>DARE-19 Didn't Pay Off for Farxiga in COVID-19 But trial may still show SGLT2 inhibitor is safe for sicker patients May 17, 2021
<乌鸦传媒>Renal Denervation Shows Worth in Resistant Hypertension Catheter-based procedure gets a win in RADIANCE-HTN TRIO May 16, 2021
<乌鸦传媒>A Call for Nuance in Cardioprotection With Early Breast Cancer Therapy Longer-term PRADA trial results weigh in for low-risk group May 16, 2021
<乌鸦传媒>FFR Disappoints as Guide for PCI on Non-Culprit Lesions in STEMI Angiography-guided strategy holds strong in FLOWER-MI trial May 16, 2021
<乌鸦传媒>LAA Occlusion During Surgery Cuts Stroke Risk Afib patients on antithrombotic therapy saw gains from add-on left atrial appendage occlusion May 16, 2021
<乌鸦传媒>Baby Aspirin on Par With Full Dose to Prevent Repeat Heart Events But landmark trial was hampered by crossover May 15, 2021
<乌鸦传媒>Strategy of DOAC After TAVR Disappoints in ATLANTIS Is aspirin alone still best after transcatheter aortic valve replacement? May 15, 2021
<乌鸦传媒>Mixed Results with ARNI Therapy for Post-MI Heart Failure Prevention Sacubitril/valsartan deemed safe, but still can't beat ramipril in PARADISE-MI trial May 15, 2021
<乌鸦传媒>Mavacamten Boosts Quality of Life in Hypertrophic Cardiomyopathy Secondary findings show big gains for more than a third of patients May 15, 2021
<乌鸦传媒>ARNI Therapy in the Hot Seat at Another Virtual ACC PARADISE-MI to provide data on Entresto for MI survivors with reduced LVEF May 14, 2021
<乌鸦传媒>ISCHEMIA Trial Puts Big Question Mark on Implications of Ischemia Subanalyses of the landmark trial show lack of correlation to outcomes Apr 01, 2020
<乌鸦传媒>Mavacamten Promising in Non-Obstructive HCM Phase II MAVERICK-HCM trial looked at safety, efficacy of myosin inhibitor Apr 01, 2020
<乌鸦传媒>DAPT Plus DOAC a Loser After Lower Limb Revascularization Three drugs post-procedure is one too many, study suggests Apr 01, 2020
<乌鸦传媒>Homozygous FH Falls to Praluent, Novel Agent Drugs succeed in cutting LDL in extra-refractory form of high cholesterol Mar 31, 2020
<乌鸦传媒>Higher On-Tx EPA Levels Explain Benefit of Vascepa Further evidence from REDUCE-IT that triglyceride lowering is not key to icosapent ethyl's effects Mar 30, 2020
<乌鸦传媒>TWILIGHT Findings Hold Strong in Diabetes, Complex PCI Ticagrelor monotherapy after brief DAPT also worked following newer-gen stent implantation Mar 30, 2020
<乌鸦传媒>DOAC Works in Cancer-Related VTE, No Tradeoff in Bleeds Apixaban monotherapy matches dalteparin in non-inferiority trial Mar 29, 2020
<乌鸦传媒>More 'Convincing' Data on BP Drop After Renal Denervation Full results reported from SPYRAL HTN-OFF MED Mar 29, 2020
<乌鸦传媒>TAVR: Promising in Low-Risk Patients With Bicuspid Anatomy However, pacemaker rate still high in experienced hands, according to early data Mar 29, 2020
<乌鸦传媒>AFib Patients Better Off With No Antiplatelet After TAVR POPular TAVI trial supports sticking to anticoagulation alone Mar 29, 2020
<乌鸦传媒>Favorable Results for DOAC After Peripheral Intervention But the devil's in the details of the VOYAGER PAD trial, expert opines Mar 28, 2020
<乌鸦传媒>Radial vs Femoral; P2Y12 Inhibitor Monotherapy; PCI With Microbubbles Advances in interventional cardiology at ACC 2019 Mar 20, 2019
<乌鸦传媒>Bempedoic Acid: Modest LDL Lowering Affirmed CLEAR Wisdom completes the phase III picture; next step, FDA review Mar 20, 2019
